Oxygenta Pharmaceutical Limited (BSE: 524636)
Health Care · Pharmaceuticals · IN
Rs63.85
-2.34% today · -21.1% 1Y
Oxygenta Pharmaceutical Limited (BSE: 524636) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $24.68M.
Over the last twelve months the share price has lost 21.1%, trading between 43.00 and 82.95.
Tweenvest scores Oxygenta Pharmaceutical Limited across four factors: quality 27/100, value 60/100, growth 82/100. Its strongest factor is growth.
524636 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $24.68M
- Revenue (TTM)
- $14.29M
- P/E
- —
- EPS
- -3.67
- Dividend yield
- —
- Beta (5Y)
- 0.75
- 52-week high
- Rs82.95
- 52-week low
- Rs43.00
- Avg volume (3M)
- —
- Shares outstanding
- 36.98M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,194.97 | -3.14% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $269.67 | -1.27% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.19 | -2.08% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.29 | -0.98% |
Figures last refreshed Aug 18, 2026.